PEPPICELLI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 3.368
EU - Europa 3.186
AS - Asia 601
AF - Africa 16
SA - Sud America 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.177
Nazione #
US - Stati Uniti d'America 3.359
PL - Polonia 1.574
RU - Federazione Russa 727
IT - Italia 385
IE - Irlanda 209
HK - Hong Kong 140
CN - Cina 138
SG - Singapore 132
SE - Svezia 117
IN - India 57
JO - Giordania 56
VN - Vietnam 53
FI - Finlandia 37
GB - Regno Unito 30
DE - Germania 27
CH - Svizzera 23
BE - Belgio 17
CI - Costa d'Avorio 14
KR - Corea 9
FR - Francia 8
CA - Canada 7
NL - Olanda 5
UA - Ucraina 5
AT - Austria 4
CZ - Repubblica Ceca 4
TW - Taiwan 4
DK - Danimarca 3
HR - Croazia 3
SK - Slovacchia (Repubblica Slovacca) 3
TR - Turchia 3
CL - Cile 2
ES - Italia 2
IL - Israele 2
IR - Iran 2
PK - Pakistan 2
AU - Australia 1
BR - Brasile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
ID - Indonesia 1
JP - Giappone 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 7.177
Città #
Warsaw 1.571
Santa Clara 829
Fairfield 436
Chandler 240
Ashburn 219
Dublin 209
Seattle 178
Woodbridge 175
Houston 146
Cambridge 132
Wilmington 126
Florence 121
Ann Arbor 111
Singapore 104
Hong Kong 91
Altamura 75
Lawrence 73
Princeton 57
Beijing 49
Dong Ket 48
Moscow 43
Boston 34
Pune 30
Buffalo 28
San Diego 27
Shanghai 27
Mumbai 20
Bern 19
Kent 19
Medford 19
Boardman 17
Falls Church 16
Helsinki 16
Abidjan 14
Brussels 14
Phoenix 14
Norwalk 9
Rome 8
London 7
Milan 7
New York 7
Redwood City 7
Seoul 7
Bari 6
Gavirate 6
Jacksonville 6
Los Angeles 6
Toronto 6
Arezzo 5
Fiesole 5
Guangzhou 5
Scandicci 5
Shenzhen 5
Cagliari 4
Frankfurt am Main 4
Hillsboro 4
Olomouc 4
Vienna 4
Bratislava 3
Bremen 3
Brescia 3
Camerino 3
Copenhagen 3
Ghent 3
Guwahati 3
Hanoi 3
Nave 3
Redmond 3
Viterbo 3
Zhengzhou 3
Andover 2
Anghiari 2
Avezzano 2
Barcelona 2
Bologna 2
Bursa 2
Central 2
Durham 2
Fabriano 2
Falkenstein 2
Gdansk 2
Genoa 2
Hangzhou 2
Iquique 2
Irkutsk 2
Karlsruhe 2
Lahore 2
Lappeenranta 2
Macerata 2
Marcianise 2
Miaoli 2
Misano Adriatico 2
Munich 2
Pioltello 2
Prato 2
Prescot 2
Rehovot 2
Rijeka 2
Riverview 2
Suwanee 2
Totale 5.570
Nome #
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 289
Chronic resveratrol treatment inhibits MRC5 fibroblast SASP-related pro-tumoral effects on melanoma cells 289
The acidic microenvironment as a possible niche of dormant tumor cells 276
Triazole RGD antagonist reverts TGFβ1-induced endothelial-to-mesenchymal transition in endothelial precursor cells 273
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells 265
Hallmarks of tumor environment: role of acidity in melanoma aggressiveness and metastatic dissemination 246
Type II CRISPR/Cas9 approach in the oncological therapy 240
Acidity of Microenvironment as a Further Driver of Tumor Metabolic Reprogramming 222
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells 218
Oleuropein, the Main Polyphenol of Olea europaea Leaf Extract, Has an Anti-Cancer Effect on Human BRAF Melanoma Cells and Potentiates the Cytotoxicity of Current Chemotherapies 205
Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma 202
Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells 180
SOX2 as a novel contributor of oxidative metabolism in melanoma cells 180
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy 176
Anoikis resistance as a further trait of acidic-adapted melanoma cells 166
Cancer glycolytic dependence as an new target of olive leaf extract 160
Integrin-targeted AmpRGD sunitinib liposomes as integrated antiangiogenic tools. 157
A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer 157
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells 146
Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis 139
Contribution of acidic melanoma cells undergoing epithelial-to-mesenchymal transition to aggressiveness of non-acidic melanoma cells. 135
Dynamic scenario of metabolic pathway adaptation in tumors and therapeutic approach 133
Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH 133
Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma Cells 129
FDG uptake in cancer: a continuing debate 128
CD63 Tetraspanin Is a Negative Driver of Epithelial-to-Mesenchymal Transition in Human Melanoma Cells 126
The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells 118
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 116
The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells 116
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells 109
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 107
Acidic pH via NF-κB favours VEGF-C expression in human melanoma cells 105
Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progression 105
Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation 104
Metabolic reprogramming as a continuous changing behavior of tumor cells 101
Extracellular acidity, a "reappreciated" trait of tumor environment driving malignancy: perspectives in diagnosis and therapy. 97
Oleuropein-enriched olive leaf extract affects BRAF melanoma cells metabolism 91
Inflammatory cytokines induce vascular endothelial growth factor-C expression in melanoma-associated macrophages and stimulate melanoma lymph node metastasis 85
Gold nanoparticles functionalized with RGD-semipeptides: a simple yet highly effective targeting system for αVβ3 integrins 85
Lactate maintainsBCR/Abl expression and signalinginChronic Myeloid Leukemia cells under nutrient restriction 84
Oleuropein affects braf melanoma cells and potentiates chemotherapy cytotoxicity 80
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs 77
TNFα receptor1 drives hypoxia-promoted invasiveness of human melanoma cells 77
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines 77
Oleuropein potentiates the cytotoxic activity of dacarbazine against melanoma cells. 75
Claisened hexafluoro inhibits metastatic spreading of amoeboid melanoma cells 73
Nintedanib-Containing Dual Conjugates Targeting αVβ6 Integrin and Tyrosine Kinase Receptors as Potential Antifibrotic Agents 72
uPAR controls vasculogenic mimicry ability expressed by drug-resistant melanoma cells. 62
miR-214-enriched extracellular vesicles released by acid-adapted melanoma cells promote inflammatory macrophage-dependent tumor trans-endothelial migration 61
An Oleocanthal-Enriched EVO Oil Extract Induces the ROS Production in Gastric Cancer Cells and Potentiates the Effect of Chemotherapy 60
Extracellular acidity as favouring factor of tumor progression and metastatic dissemination 59
Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry 43
Nintedanib-αVβ6 Integrin Ligand Conjugates Reduce TGFβ-Induced EMT in Human Non-Small Cell Lung Cancer 37
Extracellular Acidosis Differentially Regulates Estrogen Receptor β-Dependent EMT Reprogramming in Female and Male Melanoma Cells 28
Totale 7.274
Categoria #
all - tutte 19.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.257


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020797 0 0 0 0 0 112 124 168 134 91 154 14
2020/20211.077 77 128 28 142 66 74 91 87 94 187 47 56
2021/2022432 29 44 32 25 20 29 11 30 26 39 47 100
2022/20231.069 89 218 62 71 67 173 120 71 124 10 31 33
2023/2024514 13 44 55 21 29 73 29 139 16 31 34 30
2024/20251.944 88 236 158 446 788 228 0 0 0 0 0 0
Totale 7.274